• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity.肿瘤坏死因子α、碱性成纤维细胞生长因子和血管内皮生长因子在纤维蛋白基质中对人微血管内皮细胞管状结构形成的协同作用。尿激酶活性的作用。
J Cell Biol. 1996 Mar;132(6):1177-88. doi: 10.1083/jcb.132.6.1177.
2
Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression.类固醇激素和类视黄醇对纤维蛋白基质中人类微血管内皮细胞形成毛细血管样管状结构的影响与尿激酶表达有关。
Blood. 1998 Aug 1;92(3):927-38.
3
Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix.缺氧可增加人微血管内皮细胞上尿激酶受体的表达:对纤维蛋白基质中毛细血管样管形成的影响。
Blood. 2000 Oct 15;96(8):2775-83.
4
Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.尿激酶受体在纤维蛋白基质中新微血管结构形成中的作用及定位
Am J Pathol. 1999 Jun;154(6):1731-42. doi: 10.1016/S0002-9440(10)65429-6.
5
Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells.纤维蛋白和纤溶酶原激活剂在修复相关血管生成中的作用:用人内皮细胞进行的体外研究
EXS. 1997;79:391-411. doi: 10.1007/978-3-0348-9006-9_16.
6
Enhanced angiogenic capacity and urokinase-type plasminogen activator expression by endothelial cells isolated from human endometrium.从人子宫内膜分离的内皮细胞增强的血管生成能力和尿激酶型纤溶酶原激活物表达。
J Clin Endocrinol Metab. 2001 Jul;86(7):3359-67. doi: 10.1210/jcem.86.7.7651.
7
Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.血管内皮生长因子和碱性成纤维细胞生长因子对牛微血管内皮细胞中组织型纤溶酶原激活物的协同诱导作用及其在魏贝尔-帕拉德小体中的定位
Thromb Haemost. 2001 Aug;86(2):702-9.
8
Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.膜型基质金属蛋白酶介导的纤维蛋白-胶原蛋白基质中的血管生成
Blood. 2003 Mar 1;101(5):1810-7. doi: 10.1182/blood-2002-05-1593. Epub 2002 Sep 19.
9
Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.血管内皮生长因子(VEGF)-C与碱性成纤维细胞生长因子及VEGF协同作用,在体外诱导血管生成,并改变内皮细胞的细胞外蛋白水解活性。
J Cell Physiol. 1998 Dec;177(3):439-52. doi: 10.1002/(SICI)1097-4652(199812)177:3<439::AID-JCP7>3.0.CO;2-2.
10
Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices.金属蛋白酶-12对尿激酶型纤溶酶原激活物受体的蛋白水解作用:对纤维蛋白基质中血管生成的影响。
Blood. 2001 May 15;97(10):3123-31. doi: 10.1182/blood.v97.10.3123.

引用本文的文献

1
Angiogenesis: Biological Mechanisms and In Vitro Models.血管生成:生物学机制与体外模型
Ann Biomed Eng. 2025 Apr 10. doi: 10.1007/s10439-025-03721-2.
2
Distinct Hemostasis and Blood Composition in Spiny Mouse .刺毛鼠独特的止血与血液成分
Int J Mol Sci. 2024 Nov 29;25(23):12867. doi: 10.3390/ijms252312867.
3
Profound Properties of Protein-Rich, Platelet-Rich Plasma Matrices as Novel, Multi-Purpose Biological Platforms in Tissue Repair, Regeneration, and Wound Healing.富含蛋白质、富含血小板的血浆基质在组织修复、再生和伤口愈合中的新型多用途生物平台的深远特性。
Int J Mol Sci. 2024 Jul 19;25(14):7914. doi: 10.3390/ijms25147914.
4
Comparison of conjunctival pedicle flap to corneal fixation strength achieved by Tisseel® fibrin glue, ethyl cyanoacrylate adhesive, ReSure® hydrogel sealant, and conventional suturing with 8-0 VICRYL® ophthalmic suture.结膜蒂状瓣与通过Tisseel®纤维蛋白胶、氰基丙烯酸乙酯粘合剂、ReSure®水凝胶密封剂以及使用8-0 VICRYL®眼科缝线进行传统缝合所实现的角膜固定强度的比较。
Vet Ophthalmol. 2025 Mar;28(2):253-263. doi: 10.1111/vop.13197. Epub 2024 Mar 26.
5
Effect of a novel tyrosine kinase inhibitor nintedanib on bFGF and VEGF concentrations in a rabbit retinal vein occlusion model.新型酪氨酸激酶抑制剂尼达尼布对兔视网膜静脉阻塞模型中碱性成纤维细胞生长因子和血管内皮生长因子浓度的影响。
Int J Ophthalmol. 2023 Sep 18;16(9):1450-1455. doi: 10.18240/ijo.2023.09.11. eCollection 2023.
6
Use of CGF in Oral and Implant Surgery: From Laboratory Evidence to Clinical Evaluation.CGF 在口腔和种植外科中的应用:从实验室证据到临床评估。
Int J Mol Sci. 2022 Dec 2;23(23):15164. doi: 10.3390/ijms232315164.
7
Human Milk Oligosaccharides in Cord Blood Are Altered in Gestational Diabetes and Stimulate Feto-Placental Angiogenesis In Vitro.脐血中的人乳寡糖在妊娠期糖尿病中发生改变,并在体外刺激胎-胎盘血管生成。
Nutrients. 2021 Nov 26;13(12):4257. doi: 10.3390/nu13124257.
8
SUCNR1 Is Expressed in Human Placenta and Mediates Angiogenesis: Significance in Gestational Diabetes.SUCNR1 在人胎盘组织中表达并介导血管生成:在妊娠糖尿病中的意义。
Int J Mol Sci. 2021 Nov 7;22(21):12048. doi: 10.3390/ijms222112048.
9
Effect of a Topical Nonsteroidal Anti-Inflammatory Drug (0.1% Pranoprofen) on VEGF and COX-2 Expression in Primary Pterygium.局部用非甾体抗炎药(0.1% 普拉洛芬)对原发性翼状胬肉中血管内皮生长因子(VEGF)和环氧合酶 -2(COX-2)表达的影响
Front Pharmacol. 2021 Jul 9;12:709251. doi: 10.3389/fphar.2021.709251. eCollection 2021.
10
Skin substitutes are more potent than dermal or epidermal substitutes in stimulating endothelial cell sprouting.皮肤替代物在刺激内皮细胞芽生方面比真皮或表皮替代物更有效。
BMC Biomed Eng. 2019 Jul 17;1:18. doi: 10.1186/s42490-019-0018-8. eCollection 2019.

本文引用的文献

1
Upregulation of urokinase receptor expression on migrating endothelial cells.迁移内皮细胞上尿激酶受体表达上调。
J Cell Biol. 1993 Aug;122(3):673-84. doi: 10.1083/jcb.122.3.673.
2
Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells.重组可溶性尿激酶受体作为尿激酶型纤溶酶原激活剂(uPA)的清除剂。对人卵巢癌细胞增殖和侵袭的抑制作用。
FEBS Lett. 1994 Jan 10;337(2):131-4. doi: 10.1016/0014-5793(94)80259-9.
3
Vascular permeability factor (VPF, VEGF) in tumor biology.肿瘤生物学中的血管通透性因子(VPF,血管内皮生长因子)
Cancer Metastasis Rev. 1993 Sep;12(3-4):303-24. doi: 10.1007/BF00665960.
4
Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester.人静脉和微血管内皮细胞中基质金属蛋白酶表达的调控。肿瘤坏死因子α、白细胞介素1和佛波酯的作用。
Biochem J. 1993 Dec 15;296 ( Pt 3)(Pt 3):803-9. doi: 10.1042/bj2960803.
5
Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.血管内皮生长因子和碱性成纤维细胞生长因子对胶原凝胶内牛毛细血管内皮细胞增殖和条索形成的协同作用。
Lab Invest. 1993 Nov;69(5):508-17.
6
Matrix metalloproteinases. A mini-review.基质金属蛋白酶。一篇综述。
Contrib Nephrol. 1994;107:85-93.
7
Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells.在昆虫细胞中合成与组装具有功能活性的人血管内皮生长因子同型二聚体。
Eur J Biochem. 1993 Jan 15;211(1-2):19-26. doi: 10.1111/j.1432-1033.1993.tb19865.x.
8
Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.内皮细胞尿激酶型纤溶酶原激活物受体的调节。环磷酸腺苷依赖性和蛋白激酶C依赖性途径的证据。
Circ Res. 1993 Feb;72(2):330-40. doi: 10.1161/01.res.72.2.330.
9
Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expression.尿激酶受体是一种多功能蛋白:受体占据对巨噬细胞基因表达的影响。
J Clin Invest. 1995 Jul;96(1):465-74. doi: 10.1172/JCI118057.
10
Identification of the urokinase receptor as an adhesion receptor for vitronectin.鉴定尿激酶受体为玻连蛋白的粘附受体。
J Biol Chem. 1994 Dec 23;269(51):32380-8.

肿瘤坏死因子α、碱性成纤维细胞生长因子和血管内皮生长因子在纤维蛋白基质中对人微血管内皮细胞管状结构形成的协同作用。尿激酶活性的作用。

Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity.

作者信息

Koolwijk P, van Erck M G, de Vree W J, Vermeer M A, Weich H A, Hanemaaijer R, van Hinsbergh V W

机构信息

Gaubius Laboratory TNO-PG, Leiden, The Netherlands.

出版信息

J Cell Biol. 1996 Mar;132(6):1177-88. doi: 10.1083/jcb.132.6.1177.

DOI:10.1083/jcb.132.6.1177
PMID:8601593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2120755/
Abstract

In angiogenesis associated with tissue repair and disease, fibrin and inflammatory mediators are often involved. We have used three-dimensional fibrin matrices to investigate the humoral requirements of human microvascular endothelial cells (hMVEC) to form capillary-like tubular structures. bFGF and VEGF165 were unable to induce tubular structures by themselves. Simultaneous addition of one or both of these factors with TNFalpha induced outgrowth of tubules, the effect being the strongest when bFGF, VEGF165, and TNFalpha were added simultaneously. Exogenously added u-PA, but not its nonproteolytic amino-terminal fragment, could replace TNFalpha, suggesting that TNFalpha-induced u-PA synthesis was involved. Soluble u-PA receptor (u-PAR) or antibodies that inhibited u-PA activity prevented the formation of tubular structures by 59-99%. epsilon-ACA and trasylol which inhibit the formation and activity of plasmin reduced the extent of tube formation by 71-95%. TNFalpha or u-PA did not induce tubular structures without additional growth factors. bFGF and VEGF165 enhanced of the u-PAR by 72 and 46%, but TNFalpha itself also increased u-PAR in hMVEC by 30%. Induction of mitogenesis was not the major contribution of bFGF and VEGF165 because the cell number did not change significantly in the presence of TNFalpha, and tyrphostin A47, which inhibited mitosis completely, reduced the formation of tubular structures only by 28-36%. These data show that induction of cell-bound u-PA activity by the cytokine TNFalpha is required in addition to the angiogenic factors VEGF165 and/or bFGF to induce in vitro formation of capillary-like structures by hMVEC in fibrin matrices. These data may provide insight in the mechanism of angiogenesis as occurs in pathological conditions.

摘要

在与组织修复和疾病相关的血管生成过程中,纤维蛋白和炎症介质常常参与其中。我们利用三维纤维蛋白基质来研究人微血管内皮细胞(hMVEC)形成毛细血管样管状结构所需的体液条件。碱性成纤维细胞生长因子(bFGF)和血管内皮生长因子165(VEGF165)自身无法诱导管状结构的形成。将这两种因子中的一种或两种与肿瘤坏死因子α(TNFα)同时添加可诱导小管长出,当bFGF、VEGF165和TNFα同时添加时效果最强。外源性添加尿激酶型纤溶酶原激活物(u-PA)而非其无蛋白水解活性的氨基末端片段能够替代TNFα,这表明TNFα诱导的u-PA合成参与其中。可溶性尿激酶型纤溶酶原激活物受体(u-PAR)或抑制u-PA活性的抗体可使管状结构的形成减少59% - 99%。抑制纤溶酶形成和活性的ε-氨基己酸(ε-ACA)和抑肽酶可使管形成程度降低71% - 95%。若无额外的生长因子,TNFα或u-PA不会诱导管状结构的形成。bFGF和VEGF165使u-PAR分别增加72%和46%,但TNFα自身也可使hMVEC中的u-PAR增加30%。bFGF和VEGF165的主要作用并非诱导有丝分裂,因为在TNFα存在的情况下细胞数量没有显著变化,而完全抑制有丝分裂的 tyrphostin A47仅使管状结构的形成减少28% - 36%。这些数据表明,除血管生成因子VEGF165和/或bFGF外,细胞因子TNFα诱导细胞结合的u-PA活性对于在纤维蛋白基质中由hMVEC体外形成毛细血管样结构是必需的。这些数据可能为病理条件下发生的血管生成机制提供见解。